5-((3-(3-Fluoro-4-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-hexyl-2-thioxothiazolidin-4-one

Catalog No. :
ACUJZY174
CAS No. :
623939-85-5
Molecular Formula :
C26H26FN3OS2
Molecular Weight :
479.65

IUPAC Name:(Z)-5-((3-(3-fluoro-4-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-hexyl-2-thioxothiazolidin-4-one

5-((3-(3-Fluoro-4-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-hexyl-2-thioxothiazolidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-((3-(3-Fluoro-4-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-hexyl-2-thioxothiazolidin-4-one
IUPAC Name(Z)-5-((3-(3-fluoro-4-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-hexyl-2-thioxothiazolidin-4-one
MDL No.MFCD04441503
Molecular FormulaC26H26FN3OS2
Molecular Weight479.65
SMILESO=C1N(CCCCCC)C(S/C1=C\C2=CN(C3=CC=CC=C3)N=C2C4=CC=C(C)C(F)=C4)=S
InChI KeyZVDMHROESWWMOJ-KQWNVCNZSA-N
SynonymSALOR-INT L440701-1EA;(5Z)-5-([3-(3-FLUORO-4-METHYLPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]METHYLENE)-3-HEXYL-2-THIOXO-1,3-THIAZOLIDIN-4-ONE;4-Thiazolidinone, 5-[[3-(3-fluoro-4-methylphenyl)-1-phenyl-1H-pyrazol-4-yl]methylene]-3-hexyl-2-thioxo-
CAS No.623939-85-5

Synthetic Route by SureRoute

1. ACUJZY174 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNHOR457 route compound structure diagram
    ACNHOR45756347-27-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUJZY174 route product structure diagram
    ACUJZY174623939-85-5
Inquiry

2. ACUJZY174 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUJZY174 route product structure diagram
    ACUJZY174623939-85-5
Inquiry

Comments (0)